JP2016528178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528178A5 JP2016528178A5 JP2016518421A JP2016518421A JP2016528178A5 JP 2016528178 A5 JP2016528178 A5 JP 2016528178A5 JP 2016518421 A JP2016518421 A JP 2016518421A JP 2016518421 A JP2016518421 A JP 2016518421A JP 2016528178 A5 JP2016528178 A5 JP 2016528178A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- extract
- formulation according
- emulsifier
- ethyl acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 16
- 239000000284 extract Substances 0.000 claims 7
- 238000002360 preparation method Methods 0.000 claims 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 3
- 239000005642 Oleic acid Substances 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 235000006708 antioxidants Nutrition 0.000 claims 3
- 229940127089 cytotoxic agent Drugs 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 239000002024 ethyl acetate extract Substances 0.000 claims 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 3
- -1 Avastin® Chemical compound 0.000 claims 2
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 2
- 240000008397 Ganoderma lucidum Species 0.000 claims 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims 2
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 claims 2
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims 2
- 241000915604 Scutellaria barbata Species 0.000 claims 2
- 230000001476 alcoholic effect Effects 0.000 claims 2
- 229940087168 alpha tocopherol Drugs 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 150000002148 esters Chemical group 0.000 claims 2
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 2
- 231100000682 maximum tolerated dose Toxicity 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- QUANRIQJNFHVEU-UHFFFAOYSA-N oxirane;propane-1,2,3-triol Chemical compound C1CO1.OCC(O)CO QUANRIQJNFHVEU-UHFFFAOYSA-N 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 2
- 235000012424 soybean oil Nutrition 0.000 claims 2
- 239000003549 soybean oil Substances 0.000 claims 2
- 229960000984 tocofersolan Drugs 0.000 claims 2
- 235000004835 α-tocopherol Nutrition 0.000 claims 2
- 239000002076 α-tocopherol Substances 0.000 claims 2
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 239000002136 L01XE07 - Lapatinib Substances 0.000 claims 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 1
- 240000004534 Scutellaria baicalensis Species 0.000 claims 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims 1
- 229940122803 Vinca alkaloid Drugs 0.000 claims 1
- 229940110282 alimta Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000003817 anthracycline antibiotic agent Substances 0.000 claims 1
- 229940045799 anthracyclines and related substance Drugs 0.000 claims 1
- 230000000340 anti-metabolite Effects 0.000 claims 1
- 229940100197 antimetabolite Drugs 0.000 claims 1
- 239000002256 antimetabolite Substances 0.000 claims 1
- 229940120638 avastin Drugs 0.000 claims 1
- GXJABQQUPOEUTA-RDJZCZTQSA-N bortezomib Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)B(O)O)NC(=O)C=1N=CC=NC=1)C1=CC=CC=C1 GXJABQQUPOEUTA-RDJZCZTQSA-N 0.000 claims 1
- 229960004117 capecitabine Drugs 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- 190000008236 carboplatin Chemical compound 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 229940115080 doxil Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 229960001904 epirubicin Drugs 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 229940020967 gemzar Drugs 0.000 claims 1
- 229940022353 herceptin Drugs 0.000 claims 1
- BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 claims 1
- 229960004891 lapatinib Drugs 0.000 claims 1
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 1
- 229940041033 macrolides Drugs 0.000 claims 1
- 229940086322 navelbine Drugs 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- WBXPDJSOTKVWSJ-ZDUSSCGKSA-L pemetrexed(2-) Chemical compound C=1NC=2NC(N)=NC(=O)C=2C=1CCC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 WBXPDJSOTKVWSJ-ZDUSSCGKSA-L 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 239000003207 proteasome inhibitor Substances 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 claims 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 1
- 229940099039 velcade Drugs 0.000 claims 1
- GBABOYUKABKIAF-IELIFDKJSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-IELIFDKJSA-N 0.000 claims 1
- 229960002066 vinorelbine Drugs 0.000 claims 1
- CILBMBUYJCWATM-PYGJLNRPSA-N vinorelbine ditartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC CILBMBUYJCWATM-PYGJLNRPSA-N 0.000 claims 1
- 229940053867 xeloda Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361830632P | 2013-06-03 | 2013-06-03 | |
| US61/830,632 | 2013-06-03 | ||
| PCT/US2014/040771 WO2014197520A1 (en) | 2013-06-03 | 2014-06-03 | Novel formulations of botanical extracts for cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016528178A JP2016528178A (ja) | 2016-09-15 |
| JP2016528178A5 true JP2016528178A5 (enExample) | 2017-07-13 |
Family
ID=52008545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016518421A Pending JP2016528178A (ja) | 2013-06-03 | 2014-06-03 | 癌治療のための植物抽出物の新しい製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160143970A1 (enExample) |
| EP (1) | EP3003334A4 (enExample) |
| JP (1) | JP2016528178A (enExample) |
| CN (1) | CN105705153A (enExample) |
| CA (1) | CA2953283A1 (enExample) |
| SG (1) | SG11201510804UA (enExample) |
| WO (1) | WO2014197520A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022103901A1 (en) * | 2020-11-11 | 2022-05-19 | Stemsation Ip Holding Llc | Synergistic composition of food-based and organic nutrients and methods for use and manufacture |
| CN116763777A (zh) * | 2022-03-09 | 2023-09-19 | 四川育强本草生物技术有限公司 | 17-氢-9-去氢穿心莲内酯-19-硫酸酯钠在制备治疗奶牛乳房炎的药物中的用途 |
| CN114617088A (zh) * | 2022-03-14 | 2022-06-14 | 海南金雨海洋产业发展有限公司 | 一种提高东风螺免疫力的养殖方法 |
| CN114875027B (zh) * | 2022-05-11 | 2024-09-24 | 澳门科技大学 | 双链rna分子及其医药用途 |
| US20250268966A1 (en) * | 2024-02-26 | 2025-08-28 | Zhi Qiao Zhang | Method and composition for enhancing immune system |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4340781C3 (de) * | 1993-11-30 | 2000-01-27 | Novartis Ag | Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung |
| DE60117711T2 (de) * | 2001-04-02 | 2006-11-09 | Li, Hongfen | Antineoplastisches arzneimittel |
| JP5300195B2 (ja) * | 2003-09-08 | 2013-09-25 | ジェニオウス バイオメド インターナショナル インコーポレイテッド | 癌治療のための植物性薬品抽出物の組成物 |
| CN1795875A (zh) * | 2004-12-21 | 2006-07-05 | 董英杰 | 莪术油脂肪乳剂及制备方法 |
| US20110117121A1 (en) * | 2006-10-27 | 2011-05-19 | James Dao | Compositions for treatment and inhibition of pain |
| AU2011323155B2 (en) * | 2010-11-04 | 2016-05-12 | Genyous Biomed International | Combination therapy for prostate cancer using botanical compositions and bicalutamide |
-
2014
- 2014-06-03 US US14/392,116 patent/US20160143970A1/en not_active Abandoned
- 2014-06-03 EP EP14807899.1A patent/EP3003334A4/en not_active Withdrawn
- 2014-06-03 WO PCT/US2014/040771 patent/WO2014197520A1/en not_active Ceased
- 2014-06-03 JP JP2016518421A patent/JP2016528178A/ja active Pending
- 2014-06-03 CA CA2953283A patent/CA2953283A1/en not_active Abandoned
- 2014-06-03 SG SG11201510804UA patent/SG11201510804UA/en unknown
- 2014-06-03 CN CN201480043676.7A patent/CN105705153A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Song et al. | Plant-derived natural products as leads to anti-cancer drugs | |
| Atiq et al. | Anti-neoplastic potential of flavonoids and polysaccharide phytochemicals in glioblastoma | |
| JP2007505042A5 (enExample) | ||
| RU2006111441A (ru) | Композиции растительных экстрактов для лечения рака | |
| JP2010180210A5 (enExample) | ||
| Lu et al. | Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma | |
| WO2016161342A3 (en) | Nitrobenzyl derivatives of anti-cancer agents | |
| Suprasert et al. | Clinical characteristics of gynecologic cancer patients who respond to salvage treatment with Lingzhi | |
| Hwang et al. | Antifungal property of hibicuslide C and its membrane-active mechanism in Candida albicans | |
| Şekerler et al. | In vitro antihepatocellular carcinoma activity of secondary metabolites of Centaurea kilaea Boiss. | |
| JP2016528178A (ja) | 癌治療のための植物抽出物の新しい製剤 | |
| Sur et al. | A comprehensive review of the use of antioxidants and natural products in cancer patients receiving anticancer therapy | |
| CN103735653B (zh) | 一种具有抗肿瘤活性的中药提取物及其制备方法和用途 | |
| Sanyal et al. | Anti-cancer property of Lenzites betulina (L) Fr. on cervical cancer cell lines and its anti-tumor effect on HeLa-implanted mice | |
| JP2016523849A5 (enExample) | ||
| CN101455652B (zh) | 蓝萼香茶菜中二萜类化合物在制备抗癌药物中的应用 | |
| Li et al. | Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer | |
| Fodouop et al. | Bioactivity and therapeutic potential of plant extracts in cancer and infectious diseases | |
| CN103191140B (zh) | 大黄素-8-O-β-D-葡萄糖苷的抗肿瘤活性及其新用途 | |
| CN103961353B (zh) | 黄芩素与10-羟基喜树碱的药物组合物及其应用 | |
| US11607384B2 (en) | Lipid emulsified drug delivery systems for chemoprevention and treatment | |
| CN103919796B (zh) | 6-羟基山萘酚-3-氧-β-葡萄糖苷在制备抗癌药物中的应用 | |
| CN103479613A (zh) | 氟代紫杉烷类衍生物在制备治疗肝癌药物中的用途 | |
| El-Mowafy | Phytomedicines: far beyond cytotoxicity in cancer therapy. sole multitarget polypharmacology, chemopreventive and safety profiles: combinatorial synergy, chemosensitization and mitigation of chemotherapy adverse-reactions | |
| LIU et al. | Combined oxaliplatin with adenosine triphosphate tumor chemosensitivity assay (ATP-TCA) for direction of indiyidual chemotherapy of hepatocellular carcinoma |